PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
Science Advances · 15.09.2023 · 9 (37)
DOI: 10.1126/sciadv.adi2687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 15.09.2023. Verfasst von Nina Đukić und 24 weiteren Autor:innen. Beteiligte Einrichtung: Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK. Hauptthemen laut MEDLINE: Transferases, COVID-19. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
PARP14 is a mono–ADP-ribosyl transferase involved in the control of immunity, transcription, and DNA replication stress management. However, little is known about the ADP-ribosylation activity of PARP14, including its substrate specificity or how PARP14-dependent ADP-ribosylation is reversed. We show that PARP14 is a dual-function enzyme with both ADP-ribosyl transferase and hydrolase activity acting on both protein and nucleic acid substrates. In particular, we show that the PARP14 macrodomain 1 is an active ADP-ribosyl hydrolase. We also demonstrate hydrolytic activity for the first macrodomain of PARP9. We reveal that expression of a PARP14 mutant with the inactivated macrodomain 1 results in a marked increase in mono(ADP-ribosyl)ation of proteins in human cells, including PARP14 itself and antiviral PARP13, and displays specific cellular phenotypes. Moreover, we demonstrate that the closely related hydrolytically active macrodomain of SARS2 Nsp3, Mac1, efficiently reverses PARP14 ADP-ribosylation in vitro and in cells, supporting the evolution of viral macrodomains to counteract PARP14-mediated antiviral response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
- Department of Biomedicine, University of Bergen, 5020 Bergen, Norway.
- Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
- MRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter EX4 4QD, UK.
- Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.
- Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, Netherlands.
ORCID-Profile: Nina Đukić, Øyvind Strømland, Jonas Damgaard Elsborg, Deeksha Munnur, Kang Zhu, Marion Schuller, Chatrin Chatrin, Lena Duma, Osamu Suyari, Johannes Gregor Matthias Rack, Domagoj Baretić, Dorian Richard Kenneth Crudgington, Joséphine Groslambert, Gerissa Fowler, Sven Wijngaarden, Evgeniia Prokhorova, Jan Rehwinkel, Herwig Schüler, Dmitri V Filippov, Sumana Sanyal, Dragana Ahel, Michael L Nielsen, Rebecca Smith, Ivan Ahel
Förderung
- Wellcome Trust
- Medical Research Council
Zitieren
APA
Đukić, N., Strømland, Ø., Elsborg, J. D., Munnur, D., Zhu, K., Schuller, M., Chatrin, C., Kar, P., Duma, L., Suyari, O., Rack, J. G. M., Baretić, D., Crudgington, D. R. K., Groslambert, J., Fowler, G., Wijngaarden, S., Prokhorova, E., Rehwinkel, J., Schüler, H., …, & Ahel, I. (2023). PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities. Science Advances, 9(37). https://doi.org/10.1126/sciadv.adi2687
Vancouver
Đukić N, Strømland Ø, Elsborg JD, Munnur D, Zhu K, Schuller M, et al. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities. Science Advances. 2023;9(37). doi:10.1126/sciadv.adi2687
BibTeX
@article{uki2023,
author = {Đukić, Nina and Strømland, Øyvind and Elsborg, Jonas Damgaard and Munnur, Deeksha and Zhu, Kang and Schuller, Marion and Chatrin, Chatrin and Kar, Pulak and Duma, Lena and Suyari, Osamu and Rack, Johannes Gregor Matthias and Baretić, Domagoj and Crudgington, Dorian Richard Kenneth and Groslambert, Joséphine and Fowler, Gerissa and Wijngaarden, Sven and Prokhorova, Evgeniia and Rehwinkel, Jan and Schüler, Herwig and Filippov, Dmitri V and Sanyal, Sumana and Ahel, Dragana and Nielsen, Michael L and Smith, Rebecca and Ahel, Ivan},
title = {PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {37},
doi = {10.1126/sciadv.adi2687}
}
EUVIMED